In April 2019, the American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) released a set of guidelines regarding the management of psoriasis with a focus on its extracutaneous manifestations-comorbidities, mental health, psychosocial wellness, and quality of life (QOL). These guidelines provide the most up-to-date evidence on the screening and treatment recommendations for these disease comorbidities. The purpose of this review is to present the recommendations in a form that can be easily applied in clinical practice.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.12788/cutis.0309 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!